BioSpace News Archive

Fulcrum Therapeutics, Inc.®, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the Company granted non-statutory stock options to new employees.

T2 Biosystems, Inc. (NASDAQ:TTOO) today announced a collaborative relationship with Vanderbilt University Medical Center’s (VUMC) Learning Healthcare System (LHS) Platform, which unites clinical research and clinical operations to evaluate and implement new approaches to care that can improve the health of patients and the community.

MOLLI Surgical is proud to announce that our organization has been recognized on the 2023 Best Workplaces™ in Health Care list.

The Government of Canada recognizes the lifesaving impact that organ donation has on those in need of a transplantation.

aTyr Pharma, Inc. announced that the Compensation Committee of aTyr’s Board of Directors has granted two employees nonstatutory stock options to purchase an aggregate of 23,400 shares of its common stock, each with an exercise price of $2.26 per share, which is equal to the closing price of aTyr’s common stock on the Nasdaq Capital Market on June 8, 2023, the effective date of the grants.